Article Per Year (5 Year)
p-Index From 2021 - 2026
0.23
P-Index
This Author published in this journals
All Journal Jurnal Sains, Teknologi dan Kesehatan
Putri Nabila Auditia
Universitas Andalas
Computer Science & IT Engineering Materials Science & Nanotechnology Medicine & Pharmacology Public Health

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
GAMBARAN TERAPI OBAT ANTIGLAUKOMA PADA PASIEN BPJS YANG DIDIAGNOSIS GLAUKOMA DI POLIKLINIK MATA RSUP DR. M. DJAMIL PADANG Putri Nabila Auditia; Elly Usman; Fitratul Ilahi; Hendriati Hendriati; Rahmatini Rahmatini; Shinta Ayu Intan
EMPIRIS : Jurnal Sains, Teknologi dan Kesehatan Vol. 3 No. 3 (2026): EMPIRIS : Jurnal Sains, Teknologi dan Kesehatan, September 2026
Publisher : Lembaga Pendidikan dan Penelitian Manggala Institute

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.62335/empiris.v3i3.3009

Abstract

Glaucoma is the second leading cause of blindness after cataract, and glaucoma-related blindness is permanent, making treatment—primarily drug therapy—focused on preventing further damage. Prescribing antiglaucoma drugs in accordance with the National Formulary (Fornas) is important to ensure drug availability and control costs, particularly for patients covered by BPJS (national health insurance). This descriptive retrospective study aimed to describe antiglaucoma drug therapy in BPJS patients diagnosed with glaucoma at the Ophthalmology Polyclinic of Dr. M. Djamil Padang Hospital, using secondary medical record data from patients treated between July and December 2023. Total sampling yielded 116 samples meeting the inclusion and exclusion criteria. The results showed that monotherapy was prescribed more frequently than combination therapy, most often administered topically. The most common monotherapy was latanoprost (56.9%), while the most common combination was latanoprost-timolol (21.6%). Most prescribed drugs (98.7%) were not listed in the Fornas or Hospital Formulary. Monotherapy was most often given to patients with juvenile glaucoma, mild-stage disease, and intraocular pressure (IOP) ≤21 mmHg, while combination therapy was most often given to patients with absolute glaucoma, severe-stage disease, and IOP >21 mmHg
Co-Authors Hendriati, Hendriati Ilahi, Fitratul Rahmatini . Shinta Ayu Intan